股本结构
单位：万股
| 公告日期 | 2026-08-06 | 2026-05-14 | 2026-05-11 | 2026-03-04 | 2025-10-31 | 2025-10-31 |
|---|---|---|---|---|---|---|
| 证券总股本 | 6173.21 | 6204.18 | 6038.81 | 5798.44 | 5780.69 | 5237.48 |
| 普通股本 | 6173.21 | 6204.18 | 6038.81 | 5798.44 | 5780.69 | 5237.48 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-06-30 | 2026-05-13 | 2026-03-31 | 2025-12-31 | 2025-11-03 | 2025-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-06 | 6173.21 | 未披露 | 定期报告 | 2026-06-30 |
| 2026-05-14 | 6204.18 | 未披露 | 定期报告 | 2026-05-13 |
| 2026-05-11 | 6038.81 | 未披露 | 定期报告 | 2026-03-31 |
| 2026-03-04 | 5798.44 | 未披露 |
更多>>
From January 1, 2025 to December 31, 2025
Issuance of ordinary shares related to underwritten offerings
Issuance of shares to be held as treasury shares
Stock options exercised and RSUs vested/released
Warrants exercised
Vesting of earnout shares
|
2025-12-31 |
| 2025-10-31 | 5780.69 | 未披露 |
更多>>
Common Stock offered 5,432,098 shares by the company
|
2025-11-03 |
| 2025-10-31 | 5237.48 | 未披露 | 定期报告 | 2025-09-30 |
| 2025-08-21 | 5233.58 | 未披露 | 定期报告 | 2025-06-30 |
| 2025-06-05 | 5453.37 | 未披露 | 定期报告 | 2025-06-05 |
| 2025-05-08 | 5206.05 | 未披露 | 定期报告 | 2025-03-31 |
| 2025-02-14 | 4694.50 | 未披露 |
更多>>
Ordinary shares offered 5,000,000 ordinary shares by company
|
2025-02-18 |
| 2025-03-11 | 4366.24 | 未披露 |
更多>>
From January 1, 2024 to December 31, 2024
Issuance of ordinary shares related to Registered Direct Offering
Issuance of shares held as treasury shares
Vesting of earnout shares
Warrants exercised
RSUs vested
Stock options exercised
|
2024-12-31 |
| 2024-11-07 | 4194.50 | 未披露 |
更多>>
From January 1, 2024 to September 30, 2024
Issuance of ordinary shares related to Registered Direct Offering
Issuance of shares held as treasury shares
Issuance of shares in connection with warrants exercised
Stock options exercised and RSU's vested
|
2024-09-30 |
| 2024-08-27 | 4174.53 | 未披露 |
更多>>
From January 1, 2024 to June 30,2024
Issuance of ordinary shares related to Registered Direct Offering
Issuance of shares to be held as treasury shares
Stock options exercised
|
2024-06-30 |
| 2024-05-21 | 4644.37 | 未披露 |
更多>>
Increase in share capital 1,000,000 shares
|
2024-05-22 |
| 2024-05-08 | 3674.03 | 未披露 | 定期报告 | 2024-03-31 |
| 2024-03-19 | 3664.97 | 未披露 |
更多>>
From January 1, 2023 to December 31,2023
Conversion of Legacy Oculis ordinary shares and treasury shares into Oculis ordinary shares
Conversion of Legacy Oculis long-term financial debt into Oculis ordinary shares
Issuance of ordinary shares to PIPE investors
Issuance of ordinary shares under CLA
Issuance of ordinary shares to EBAC shareholders
Proceeds from sale of shares in public offering
Stock option exercised
Issuance of shares in connection with warrant exercises
|
2023-12-31 |
| 2023-11-15 | 3659.80 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-08-30 | 3643.54 | 未披露 | 定期报告 | 2023-06-30 |
| 2023-06-02 | 3623.34 | 未披露 |
更多>>
Common Stock offered by the company 3,500,000 shares
|
2023-06-05 |
| 2023-05-30 | 3273.34 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-02-03 | 3458.89 | 未披露 | 定期报告 | 2023-03-03 |
| 2021-08-18 | 1639.86 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Forfeiture of Class B ordinary shares
Sale of units in initial public offering, less allocation to derivative warrant liabilities, gross (over-allotment)
Sale of units in private placement, less allocation to derivative warrant liabilities, gross (over-allotment)
Shares subject to possible redemption
|
2021-06-30 |
| 2021-06-22 | 1639.86 | 未披露 | 定期报告 | 2021-06-21 |
| 2021-03-17 | 1544.00 | 未披露 | 定期报告 | 2021-05-18 |
From January 1, 2025 to December 31, 2025
Issuance of ordinary shares related to underwritten offerings
Issuance of shares to be held as treasury shares
Stock options exercised and RSUs vested/released
Warrants exercised
Vesting of earnout shares
Common Stock offered 5,432,098 shares by the company
Ordinary shares offered 5,000,000 ordinary shares by company
From January 1, 2024 to December 31, 2024
Issuance of ordinary shares related to Registered Direct Offering
Issuance of shares held as treasury shares
Vesting of earnout shares
Warrants exercised
RSUs vested
Stock options exercised
From January 1, 2024 to September 30, 2024
Issuance of ordinary shares related to Registered Direct Offering
Issuance of shares held as treasury shares
Issuance of shares in connection with warrants exercised
Stock options exercised and RSU's vested
From January 1, 2024 to June 30,2024
Issuance of ordinary shares related to Registered Direct Offering
Issuance of shares to be held as treasury shares
Stock options exercised
Increase in share capital 1,000,000 shares
From January 1, 2023 to December 31,2023
Conversion of Legacy Oculis ordinary shares and treasury shares into Oculis ordinary shares
Conversion of Legacy Oculis long-term financial debt into Oculis ordinary shares
Issuance of ordinary shares to PIPE investors
Issuance of ordinary shares under CLA
Issuance of ordinary shares to EBAC shareholders
Proceeds from sale of shares in public offering
Stock option exercised
Issuance of shares in connection with warrant exercises
Common Stock offered by the company 3,500,000 shares
From March 31, 2021 to June 30, 2021
Forfeiture of Class B ordinary shares
Sale of units in initial public offering, less allocation to derivative warrant liabilities, gross (over-allotment)
Sale of units in private placement, less allocation to derivative warrant liabilities, gross (over-allotment)
Shares subject to possible redemption